A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Epistemonikos ID: 2cd051605610c31043f086d8a03b6115d09c2bf7
First added on: Dec 18, 2025